Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
2229 Results for "
growth factor
" in MedChemExpress (MCE) Product Catalog:
Products (2229)
2229 Results for "growth factor" in MCE Product Catalog:
170
170 Publications Verification
Cat. No.: HY-P7118
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB1; Transforming growth factor Beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-Beta-1; CED; TGF-Beta1; Transforming growth factor Beta-1 Proprotein; IBDIMDE; Prepro-Transforming growth factor Beta-1;
146
146 Cited Publications
Synonyms: Vitamin A acid; all-trans-Retinoic acid; ATRA
113
113 Cited Publications
Cat. No.: HY-18723
CAS No.: 448947-81-7
Target:
Research Areas:
Yoda 1 is a potent and selective Piezo1 agonist. Yoda 1 activates purified Piezo1 channels. Yoda 1 potently inhibits macropinocytosis induced by epidermal growth factor (EGF). Yoda 1 enhances Ca 2+ influx followed by activation of the calcium-activated potassium channel KCa3.1 and inhibition of Rac1 activation .
109
109 Cited Publications
Target:
Research Areas:
Cardiovascular Disease Metabolic Disease Inflammation/Immunology Cancer
PX-478 is a multifunctional HIF-1α inhibitor with properties including radiosensitization, autophagy activation, and lipid accumulation inhibition. PX-478 also blocks hypoxia-induced VEGF production and regulates β-cell phenotypes under hypoxic conditions. PX-478 induces cell cycle arrest and DNA damage, restores autophagic function, reduces foam cell formation, and maintains glucose homeostasis. PX-478 is widely used in research on related diseases such as human tumors (e.g., prostate cancer), type 2 diabetes, and atherosclerosis .
103
69
69 Cited Publications
Cat. No.: HY-P7117
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB1; Transforming growth factor Beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-Beta-1; CED; TGF-Beta1; Transforming growth factor Beta-1 Proprotein; IBDIMDE; Prepro-Transforming growth factor Beta-1;
63
63 Cited Publications
Cat. No.: HY-P70445
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL4; B_cell Stimulatory factor 1; Interleukin 4; B-Cell Stimulatory factor 1; IL-4; B Cell growth factor 1; Lymphocyte Stimulatory factor 1; Binetrakin; Interleukin-4; Pitrakinra; BCGF-1; MGC79402; BCGF1; BSF-1; BSF1
63
Research Areas:
Lenalidomide (CC-5013), a derivative of Thalidomide, acts as molecular glue. Lenalidomide is an orally active immunomodulator. Lenalidomide (CC-5013) is a ligand of ubiquitin E3 ligase cereblon (CRBN), and it causes selective ubiquitination and degradation of two lymphoid transcription factors, IKZF1 and IKZF3, by the CRBN-CRL4 ubiquitin ligase. Lenalidomide (CC-5013) specifically inhibits growth of mature B-cell lymphomas, including multiple myeloma, and induces IL-2 release from T cells .
63
Research Areas:
Lenalidomide hemihydrate (CC-5013 hemihydrate), a derivative of Thalidomide, acts as molecular glue. Lenalidomide hemihydrate is an orally active immunomodulator. Lenalidomide hemihydrate (CC-5013 hemihydrate) is a ligand of ubiquitin E3 ligase cereblon (CRBN), and it causes selective ubiquitination and degradation of two lymphoid transcription factors, IKZF1 and IKZF3, by the CRBN-CRL4 ubiquitin ligase. Lenalidomide hemihydrate (CC-5013 hemihydrate) specifically inhibits growth of mature B-cell lymphomas, including multiple myeloma, and induces IL-2 release from T cells .
60
60 Cited Publications
Cat. No.: HY-P7044
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL6; Hybridoma growth factor; Prev. IFNB2; IFN-Beta-2; IL-6; BSF-2; Interleukin-6; CDF; BSF2; Interleukin 6 (Interferon, Beta 2); HGF; B-Cell Differentiation factor; HSF; Truncated Interleukin 6; B-Cell Stimulatory factor 2; Interferon, Beta 2; CTL Differ
57
57 Cited Publications
Cat. No.: HY-P70543
Purity: ≥ 95%, as determined by reducing SDS-PAGE or Bis-Tris PAGE.
Synonyms: TGFB1; Transforming growth factor Beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-Beta-1; CED; TGF-Beta1; Transforming growth factor Beta-1 Proprotein; IBDIMDE; Prepro-Transforming growth factor Beta-1;
55
Research Areas:
54
54 Cited Publications
Cat. No.: HY-P7080
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL4; B_cell Stimulatory factor 1; Interleukin 4; B-Cell Stimulatory factor 1; IL-4; B Cell growth factor 1; Lymphocyte Stimulatory factor 1; Binetrakin; Interleukin-4; Pitrakinra; BCGF-1; MGC79402; BCGF1; BSF-1; BSF1
43
43 Cited Publications
Cat. No.: HY-P7004
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: FGF2; BFGF; Prev. FGFB; Basic Fibroblast growth factor; Fibroblast growth factor 2 (Basic); Fibroblast growth factor; Heparin-Binding growth factor 2; Prostatropin; HBGF-2; FGF2A; FGF-2; FGF; Fibroblast growth factor 2; Basic Fibroblast growth factor BFGF
31
31 Cited Publications
Synonyms: AXL1717; Picropodophyllotoxin; PPP
31
31 Cited Publications
Cat. No.: HY-P70648
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: TGFB1; Transforming growth factor Beta1; Prev. TGFB; Camurati-Engelmann Disease; Prev. DPD1; Latency-Associated Peptide; TGFbeta; TGF-Beta-1; CED; TGF-Beta1; Transforming growth factor Beta-1 Proprotein; IBDIMDE; Prepro-Transforming growth factor Beta-1;
31
31 Cited Publications
Cat. No.: HY-P7063
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL6; Hybridoma growth factor; Prev. IFNB2; IFN-Beta-2; IL-6; BSF-2; Interleukin-6; CDF; BSF2; Interleukin 6 (Interferon, Beta 2); HGF; B-Cell Differentiation factor; HSF; Truncated Interleukin 6; B-Cell Stimulatory factor 2; Interferon, Beta 2; CTL Differ
29
29 Cited Publications
Cat. No.: HY-P7055
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: PDGFB; Platelet-Derived growth factor 2; Prev. SIS; PDGF Subunit B; Platelet-Derived growth factor Beta Polypeptide; PDGF2; Platelet-Derived growth factor Subunit B; Platelet-Derived growth factor, Beta Polypeptide (Oncogene SIS); Platelet-Derived growth
29
27
27 Cited Publications
Cat. No.: HY-P7018
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IGF1; Somatomedin-C; Insulin Like growth factor 1; IGF1A; IGF-I; MGF; Insulin-Like growth factor 1; Insulin-Like growth factor IB; Insulin-Like growth factor I; Insulin-Like growth factor-I; IGFI; Alternative Protein IGF1; IGF; Somatomedin C; Insulin-Like
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
